CHINESE JOURNAL OF MEDICINAL GUIDE >
Research on the Regulatory Practices of the US FDA on Aesthetic Devices
Received date: 2025-07-07
Revised date: 2025-10-31
Accepted date: 2025-12-24
Online published: 2026-01-26
Objective： To explore the regulatory philosophy and characteristics of the US Food and Drug Administration （FDA） regarding aesthetic devices， provide references for the regulation of similar products in China， and facilitate the high-quality development of the industry.Methods： By searching FDA Total Product Life Cycle （TPLC） database， product classification database， PMA database， 510（k） database， and De Novo databases， to review the classification of medical aesthetic devices ， the corresponding market approval pathways， the number of adverse events， and risk control measures in the production and use phase， and to summarize FDA's classification management policies and regulatory requirements for aesthetic devices， so ao to provide reference for China's scientific regulation. Results and Conclusions： FDA's definition of medical devices includes aesthetic devices. Through classification regulations， special control guidelines， official website documents， and other regulatory documents， it clarifies classifications and specific regulatory requirements of aesthetic devices. Based on product risks， targeted regulatory measures have been formulated for both the production and use phases， with particular emphasis on the use phase， and a series of information required for the safe use of aesthetic devices have been provided. FDA emphasizes full-chain management of aesthetic devices to ensure safety throughout the product life-cycle， as well as multi-departmental coordination. The above regulatory practices provide valuable reference for the regulation of aesthetic devices in China.
ZHANG Chunqing, ZHOU Liangbin, WANG Yue, ZHU Jiong, LU Yong
.
Research on the Regulatory Practices of the US FDA
on Aesthetic Devices
［1］ 姜中蛟，李一洲.家用医疗美容仪器光辐射测量方法研究与实现［J］.中国计量，2025，（6）：134-137.
［2］ 马力，王韵晴，刘立科，等.家用光脱毛仪法规和标准现状分析［J］.中国医疗器械杂志，2021，45（5）：559-562.
［3］ 温莉茵，刘蕊，董谦，等.我国可用于医疗美容的无源医疗器械分类情况的分析［J］.中国医疗器械信息，2024，30（3）：7-9.
［4］ 吴静，金乐.美国医疗器械不良事件监测体系及MAUDE数据库在医疗器械注册申报中的应用［J］.中国医疗器械杂志，2024，48（4）：451-456.
［5］ 车宇航，郑益略，黄长瑾，等.整形与美容医疗器械临床试验风险管理探讨［J］.中国医院，2021，25（5）：91-93.
［6］ 王伟东，孙宝刚，彭峰云.医疗美容行业监管政策梳理及监管趋势分析［J］.中国市场，2024，（13）：82-86.
［7］ U.S. Food and Drug Administration. How to determine if your product is a medical device ［EB/OL］.（2022-09-29）［2025-06-26］. https：//www.fda.gov/medical-devices/classify-your-medical-device/how-determine-if-your-product-medical-device.
［8］ United States Congress. Federal Food， Drug， and Cosmetic Act［Z］.2021 （Amendment）.
［9］ U.S. Food and Drug Administration. Aesthetic （Cosmetic） Devices［EB/OL］.（2022-12-07）［2025-06-26］.https：//www.fda.gov/medical-devices/products-and-medical-procedures/aesthetic-cosmetic-devices.
［10］ U.S. Food and Drug Administration. Regulatory Considerations for Microneedling Products ［Z］.2020-11-10.
［11］ U.S. Food and Drug Administration. Product Classification Database ［EB/OL］.（2025-06-23）［2025-06-26］.https：//www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/PCDSimpleSearch.cfm.
［12］ Code of Federal Regulations. Title 21 Food and Drugs ［EB/OL］.（2025-06-24）［2025-06-26］.https：//www.ecfr.gov/current/title-21
［13］ U.S. Food and Drug Administration. TPLC - Total Product Life Cycle database［EB/OL］.（2025-06-23）［2025-06-26］.https：//www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfTPLC/tplc.cfm.
［14］ U.S. Food and Drug Administration. Premarket Approval （PMA） Database ［EB/OL］.（2025-06-16）［2025-06-26］.https：//www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm.
［15］ U.S. Food and Drug Administration. 510（k） Premarket Notification ［EB/OL］.（2025-06-23）［2025-06-26］.https：//www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm.
［16］ U.S. Food and Drug Administration. Device Classification under Section 513（f）（2）（De Novo） Database［EB/OL］.（2025-06-23）［2025-06-26］.https：//www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/denovo.cfm./
| 〈 |
|
〉 |